Framework agreement for pharmaceutical products in 13 lots (1/DLII6/VM131)

Place
Germany (delivery locations as set out in the performance specification, Annex 1)
Deadline for receipt of tenders
07:00 AM · UTC
Contract value
Not stated in the notice
Lots
13 lots
Contract period
Estimated 1 February 2027 to 31 January 2029 (the conclusion date is an estimate)
Published
October 27, 2026
TED notice 747795-2026 (HTML view, change notice) and canonical snapshot

Overview

The Federal Office for Infrastructure, Environmental Protection and Services of the Bundeswehr is tendering a framework agreement for pharmaceutical products in 13 lots. The lots include esketamine injection, desloratadine and pivmecillinam tablets, tranexamic acid, insulin, promethazine, dexmedetomidine, glucose, ipramol inhalation solution, paracetamol suppositories, naloxone, ibuprofen tablets and brivudine tablets. Each lot title states a quantity, for example 38,565 BT for lot 1 and 12,287,200 EA for lot 12. The estimated lot term runs from 1 February 2027 to 31 January 2029. Awards use an evaluation matrix (40) and price (60). Bids are due on 23 November 2026 at 08:00 Central European Time.

Information based on the public notice

What the buyer needs

A framework agreement for 13 pharmaceutical product lots for the Bundeswehr, mainly medicines and medical supplies such as injection solutions, tablets, suppositories and inhalation ampoules. Each lot has its own quantity, and the lot quantities are stated in the lot titles with their packaging units. The notice gives the product list but not the delivery locations, which are in Annex 1 of the framework agreement.

  • Bidders provide a self-declaration that no exclusion grounds apply under sections 123 and 124 GWB (procurement document VM131_12_B-V034).
  • A bidder may submit tenders for up to 13 lots and may be awarded up to 13 lots.
  • Bids must be submitted electronically on evergabe-online.de in German. Electronic catalogues are not allowed, and each bidder may submit one tender only.
  • The buyer may ask bidders to supplement missing company documents under section 56(2) VgV.

Lots

LOT-0001 ·Los 1 - 38.565 BT ESKETAMIN 25MG/ML INJ.-LSG. DSFL. 10ML

LOT-0002 ·Los 2 - 4.000 EA DESLORATADIN 5MG TABLETTE

LOT-0003 ·Los 3 - 8.640 EA PIVMECILLINAM TABLETTEN

LOT-0004 ·Los 4 - 33.770 AM TRANEXAMSAEURE INJE

LOT-0005 ·Los 5 - 2.165 BT INSULIN INJEKTION

LOT-0006 ·Los 6 - 480 BT PROMETHAZIN 20MG/ML TRPF

LOT-0007 ·Los 7 - 3.360 BT DEXMEDETOMIDIN 1MG/10ML INJ

LOT-0008 ·Los 8 - 40.980 AM GLUCOSTERIL INJ 40% 10ML /20

LOT-0009 ·Los 9 - 5.780 AM IPRAMOL TEVA 0,5+2,5MG/2,5ML INH.AMP /20

LOT-0010 ·Los 10 - 1.200 EA PARACETAMOL 250MG SUPPOSITORIEN

LOT-0011 ·Los 11 - 36.650 AM NALOXONHYDROCHLORID INJEKTION

LOT-0012 ·Los 12 - 12.287.200 EA IBUPROFEN TABLETTEN 400MG

LOT-0013 ·Los 13 - 64.148 EA BRIVUDIN 125MG TABLETTE

Tender details

Buyer
Bundesamt für Infrastruktur, Umweltschutz und Dienstleistungen der Bundeswehr
Country
Germany
Procedure
Open procedure, flagged as accelerated, framework agreement partly with and partly without reopening of competition
Classification
Pharmaceuticals and laboratory supplies · CPV 33600000
Notice reference
747795-2026
Subject
Pharmaceutical products, 13 lots (CPV 33600000)
Deadline for receipt of tenders
23 November 2026 at 08:00 CET (UTC+01:00), 07:00 UTC
Opening of tenders
23 November 2026 at 08:00 CET (UTC+01:00)
Estimated lot term
1 February 2027 to 31 January 2029
Award criteria
Evaluation matrix, weight 40; price, weight 60
Tender validity
5 months
Review body
Bundeskartellamt, Vergabekammer des Bundes

What to check in the tender documents

  • The notice gives no estimated value for the framework agreement or for any lot.
  • The procurement documents on evergabe-online.de were not read, so the performance specification, delivery locations (Annex 1), price sheets and the evaluation matrix are not reviewed here.
  • The change notice gives no change description (the field shows a dash), so what changed from the earlier notice is not stated.
  • The notice gives no award date and no estimated date of award.
Get started with Ziva

Original notice

Read the original description

1/DLII6/VM131 - RV div. Arzneimittel

1/DLII6/VM131 - RV div. Arzneimittel

Official source: TED notice 747795-2026 (HTML view, change notice) and canonical snapshot ↗